References
Original article
Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet https://doi.org/10.1016/S0140-6736(23)00772-9 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. New anti-angiogenic option for mCRC. Nat Rev Clin Oncol 20, 579 (2023). https://doi.org/10.1038/s41571-023-00800-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00800-y
- Springer Nature Limited